PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-15.45%
Negative net income growth while MRVL stands at 106.80%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-4.17%
Both reduce yoy D&A, with MRVL at -10.90%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-35.71%
Negative yoy deferred tax while MRVL stands at 150.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
13.46%
SBC growth well above MRVL's 3.03%. Michael Burry would flag major dilution risk vs. competitor’s approach.
206.08%
Slight usage while MRVL is negative at -133.98%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
240.91%
AR growth well above MRVL's 56.63%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-58.82%
Negative yoy inventory while MRVL is 76.25%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-190.00%
Both negative yoy AP, with MRVL at -11.62%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
184.05%
Some yoy usage while MRVL is negative at -372.68%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-6.67%
Both negative yoy, with MRVL at -52.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
100.39%
Some CFO growth while MRVL is negative at -19.95%. John Neff would note a short-term liquidity lead over the competitor.
11.76%
Lower CapEx growth vs. MRVL's 45.38%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.97%
We reduce yoy sales while MRVL is 33.92%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-200.00%
We reduce yoy other investing while MRVL is 3321.48%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-7.04%
We reduce yoy invests while MRVL stands at 11989.07%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-200.00%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.